Phase I/II Study for RV-001

JRCT ID: jRCT2033240611

Registered date:15/01/2025

Basic Information

• Recruitment status: Recruiting
• Health condition(s) or Problem(s) studied: Retinitis Pigmentosa
• Date of first enrollment: 01/02/2025
• Target sample size: 15
• Study type: Interventional
• Intervention(s): Administration of investigational product

Outcome(s)

• Primary Outcome: Dose-Limiting Toxicity

Key inclusion & exclusion criteria

• Age minimum: >= 18age old
• Age maximum: Not applicable

Include criteria

18 years old and up at the time of ICF signature

Diagnosis of non-syndromic Retinitis Pigmentosa

Exclude criteria

Diagnosed with an inherited retinal degenerative disease other than non-syndromic Retinitis Pigmentosa or systemic symptoms, such as hearing loss.

Prior receipt of any genetic, cell-based or optogenetic therapy for Retinitis Pigmentosa, or prior participation in clinical trials for such therapies.

Related Information

• Primary Sponsor: Katada Yusaku